35 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
ability to recruit and enroll suitable patients in our clinical trials; the potential attributes and benefits of our product candidates; our ability … ; the design of the trial; its ability to recruit clinical trial investigators with the appropriate competencies and experience; competing clinical trials
424B5
lbw5vxgrcsa jnnw991
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
ydlfuy7vkmrxfrobvdg
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B3
cnpqouo
11 Jul 22
Prospectus supplement
4:32pm
POS AM
yzdz8v qtygozcns1gt
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
2shc2v ubni6up
1 Jul 22
Shelf registration
4:13pm
424B3
bze sn756s
13 May 22
Prospectus supplement
8:18am
424B3
7q2dsl2lo2 nvn
31 Mar 22
Prospectus supplement
11:42am
POS AM
k8it 58veb0zem
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
cq6qcxppad8jl0q
12 Nov 21
Prospectus supplement
8:41am
424B3
4klhklp23mz6finm 09
13 Aug 21
Prospectus supplement
5:25pm